Health


 How Are Structural Headwinds Shaping Avantor’s (NYSE:AVTR) Strategy?

How Are Structural Headwinds Shaping Avantor’s (NYSE:AVTR) Strategy?

April 25, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Avantor’s revenue declined in the recent quarter, missing market expectations.,The company’s five-year growth rate has remained below industry benchmarks.,The life sciences tools sector continues to face mixed structural challenges and dem...

 Envestnet Asset Management Inc. Increases Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Stock

Envestnet Asset Management Inc. Increases Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Stock

April 24, 2025 03:01 AM PDT| By Team Kalkine Media

Highlights,Notable increase in institutional investments in the recent quarter,Analysts express mixed opinions on the stock's future performance,Overview of Amicus Therapeutics' market standing and product portfolio,Amicus Therapeutics (NASDAQ:FOLD)...

 Could Institutional Flows Reflect Changing Sentiment at Catalyst?

Could Institutional Flows Reflect Changing Sentiment at Catalyst?

April 24, 2025 02:30 AM PDT| By Team Kalkine Media

Could Institutional Flows Reflect Changing Sentiment at Catalyst?

 Can Omnicell Maintain Institutional Momentum Amid Market Dynamics?

Can Omnicell Maintain Institutional Momentum Amid Market Dynamics?

April 24, 2025 02:30 AM PDT| By Team Kalkine Media

Can Omnicell Maintain Institutional Momentum Amid Market Dynamics?

 Could Institutional Moves Fuel Twist’s Next Chapter?

Could Institutional Moves Fuel Twist’s Next Chapter?

April 24, 2025 02:30 AM PDT| By Team Kalkine Media

Could Institutional Moves Fuel Twist’s Next Chapter?

 Strategic Developments and Market Activity in AMN Healthcare Services. (NYSE:AMN)

Strategic Developments and Market Activity in AMN Healthcare Services. (NYSE:AMN)

April 24, 2025 02:24 AM PDT| By Team Kalkine Media

Highlights:,Institutional Activity:,Several major financial entities expanded their positions in AMN Healthcare Services, indicating active engagement within the healthcare sector.,Rating Updates:,Revisions in stock evaluations reflect a balanced app...

 Leerink Partners Releases Negative Forecast for UNH Earnings

Leerink Partners Releases Negative Forecast for UNH Earnings

April 24, 2025 01:58 AM PDT| By Team Kalkine Media

Highlights,UnitedHealth Group’s earnings estimates have been revised for the upcoming quarterly period.,The company retains a dominant presence in the healthcare sector through diverse service divisions.,Trading activity shows steady interest from in...

 Invesco Ltd. Reduces Its Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Invesco Ltd. Reduces Its Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

April 24, 2025 01:51 AM PDT| By Team Kalkine Media

Highlights,Institutional Stake Adjustments,: Invesco Ltd. reduced its shareholding in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) during the most recent quarter, reflecting shifting investor strategies.,Stock Performance,: ACADIA Pharmaceuticals' stock...

 What Makes Amicus Therapeutics (NASDAQ:FOLD) a Focal Point in Rare Disease Research?

What Makes Amicus Therapeutics (NASDAQ:FOLD) a Focal Point in Rare Disease Research?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Russell Investments Group significantly expanded its position in Amicus Therapeutics during the fourth quarter.,Multiple financial entities adjusted their holdings, reflecting renewed engagement with the biotechnology firm.,Amicus continue...

 What Role Do Formulation Technologies Play in Collegium Pharmaceutical Inc. (NASDAQ:COLL)?

What Role Do Formulation Technologies Play in Collegium Pharmaceutical Inc. (NASDAQ:COLL)?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,JPMorgan Chase & Co. significantly reduced its stake in Collegium Pharmaceutical Inc. during the fourth quarter.,Other institutional stakeholders, including Royce & Associates and Rhumbline Advisers, reported varied activity.,Collegium Pha...

 Why Is iTeos Therapeutics Inc. (NASDAQ:ITOS) Gaining Ground in Biopharma Portfolios?

Why Is iTeos Therapeutics Inc. (NASDAQ:ITOS) Gaining Ground in Biopharma Portfolios?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Russell Investments Group Ltd. increased its holdings in iTeos Therapeutics during the fourth quarter.,Additional firms such as SG Americas Securities and Wells Fargo & Company MN adjusted their positions.,iTeos Therapeutics focuses on the...

 Is OrthoPediatrics (NASDAQ:KIDS) Becoming a Key Focus in Pediatric Medical Technology?

Is OrthoPediatrics (NASDAQ:KIDS) Becoming a Key Focus in Pediatric Medical Technology?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Geode Capital Management and Wellington Management Group expanded their holdings in OrthoPediatrics.,Triodos Investment Management significantly increased its position in the company.,OrthoPediatrics continues to develop specialized pediat...

 Is Institutional Participation Defining the Trajectory of Celcuity (NASDAQ:CELC)?

Is Institutional Participation Defining the Trajectory of Celcuity (NASDAQ:CELC)?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Geode Capital Management expanded its stake in Celcuity Inc. during the recent quarter.,Multiple institutional firms revised their positions in the company.,Celcuity maintains a strong liquidity profile within the biotechnology space.,Celc...

 Is Akebia Therapeutics (NASDAQ:AKBA) Gaining Strength from Institutional Backing in the Biopharma Space?

Is Akebia Therapeutics (NASDAQ:AKBA) Gaining Strength from Institutional Backing in the Biopharma Space?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Geode Capital Management increased its position in Akebia Therapeutics during the fourth quarter.,The company recorded quarterly revenue surpassing market expectations.,Akebia continues development of treatments for anemia associated with...

 Is Blueprint Medicines (NASDAQ:BPMC) Becoming a Pivotal Name in Targeted Oncology?

Is Blueprint Medicines (NASDAQ:BPMC) Becoming a Pivotal Name in Targeted Oncology?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Cerity Partners LLC initiated a new position in Blueprint Medicines during the fourth quarter.,Vanguard Group Inc. and Wellington Management Group LLP significantly increased their stakes.,Blueprint Medicines is focused on advancing target...

 Is Acadia Healthcare (NASDAQ:ACHC) Entering a New Phase of Institutional Rebalancing?

Is Acadia Healthcare (NASDAQ:ACHC) Entering a New Phase of Institutional Rebalancing?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Invesco Ltd. reduced its holdings in Acadia Healthcare by a substantial margin in the fourth quarter.,Multiple firms including Nisa Investment Advisors LLC and Fifth Third Bancorp adjusted their stakes.,Acadia Healthcare operates a nationw...

 What Role Does Innovation Play in Neogen’s (NASDAQ:NEOG) Market Resilience?

What Role Does Innovation Play in Neogen’s (NASDAQ:NEOG) Market Resilience?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Major institutions, including Bank of Montreal and Vanguard Group Inc., adjusted their holdings in Neogen.,Norges Bank reported a significant investment in Neogen during the latest quarter.,Neogen continues to focus on food and animal safe...

 Is Verona Pharma (NASDAQ:VRNA) Paving a New Path in Respiratory Care?

Is Verona Pharma (NASDAQ:VRNA) Paving a New Path in Respiratory Care?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Institutional investors, including Wells Fargo, significantly increased their holdings in Verona Pharma.,Key product candidate ensifentrine is in advanced clinical development.,Broad institutional ownership reflects continued backing in th...

 What Do Stake Increases Reveal About Qiagen’s (NYSE:QGEN) Industry Standing?

What Do Stake Increases Reveal About Qiagen’s (NYSE:QGEN) Industry Standing?

April 24, 2025 12:00 AM PDT| By Team Kalkine Media

Highlights,Wells Fargo & Company MN increased its stake in Qiagen by a notable margin in the fourth quarter.,Institutional ownership in Qiagen stands at approximately seventy percent.,The company maintains healthy financial metrics, including solid r...

 Why Is This Healthcare Giant Gaining Market Traction Again?

Why Is This Healthcare Giant Gaining Market Traction Again?

April 23, 2025 12:42 PM PDT| By Team Kalkine Media

Why Is This Healthcare Giant Gaining Market Traction Again?

Recent Articles






Investing Tips

Previous Next